Title: Diarrhea - Pipeline Review, H2 2015
1Diarrhea - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2 Report Overview
- Scope
- The report provides a snapshot of the global
therapeutic landscape of Diarrhea - The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RandD brief, licensing and
collaboration details and other developmental
activities - The report reviews key players involved in the
therapeutics development for Diarrhea and enlists
all their major and minor projects - The report summarizes all the dormant and
discontinued pipeline projects - A review of the Diarrhea products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources - Pipeline products coverage based on various
stages of development ranging from
pre-registration till discovery and undisclosed
stages - A detailed assessment of monotherapy and
combination therapy pipeline projects - Coverage of the Diarrhea pipeline on the basis of
target, MoA, route of administration and molecule
type - Latest news and deals relating related to
pipeline products - Read More At http//www.researchbeam.com/diarrhe
a-pipeline-review-h2-2015-market
3 Table of Content
Table of Contents 2List of Tables 5List of
Figures 6Introduction 7Global Markets Direct
Report Coverage 7Diarrhea Overview
8Therapeutics Development 9Pipeline Products
for Diarrhea - Overview 9Pipeline Products for
Diarrhea - Comparative Analysis 10Diarrhea -
Therapeutics under Development by Companies
11Diarrhea - Therapeutics under Investigation by
Universities/Institutes 13Diarrhea - Pipeline
Products Glance 14Late Stage Products
14Clinical Stage Products 15Early Stage
Products 16Diarrhea - Products under Development
by Companies 17Diarrhea - Products under
Investigation by Universities/Institutes
20Diarrhea - Companies Involved in Therapeutics
Development 21A. Menarini Industrie
Farmaceutiche Riunite Srl 21Ache Laboratorios
Farmaceuticos S/A 22
4 Report Overview
- Reasons to buy
- Provides strategically significant competitor
information, analysis, and insights to formulate
effective RandD development strategies - Identify emerging players with potentially strong
product portfolio and create effective
counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding
the focus areas of leading companies - Identify and understand important and diverse
types of therapeutics under development for
Diarrhea - Plan mergers and acquisitions effectively by
identifying key players of the most promising
pipeline - Devise corrective measures for pipeline projects
by understanding Diarrhea pipeline depth and
focus of Indication therapeutics - Develop and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope - Modify the therapeutic portfolio by identifying
discontinued projects and understanding the
factors that drove them from pipeline - Enquire At http//www.researchbeam.com/diarrhea-
pipeline-review-h2-2015-market/enquire-about-repor
t
5 FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/diarrhea-pipeline-revi
ew-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com